Key HighlightsNvidia stock gained modestly in pre-bell trading ahead of its highly anticipated quarterly resultsIntuit plummeted approximately 12% following disappointing fiscal 2027 revenue projectionsTechnology software names declined across the board, including ServiceNow, Adobe, Salesforce, and PalantirBitcoin retreated to approximately $78,500 from recent peaks near $81,000, pressuring cryptocurrency-related equitiesBiohaven jumped 13% on news of a licensing agreement with SK Biopharmaceuticals valued at up to $795 millionWednesday’s trading session began with hesitation as market participants positioned themselves for Nvidia’s quarterly financial disclosure, scheduled for release after the market close. Industry observers view these results as potentially pivotal for the ongoing artificial intelligence investment narrative.Nvidia stock advanced 0.3% during pre-market hours following a 2.2% climb in the prior session that snapped a week-long decline. Fellow semiconductor companies Intel and Broadcom also posted modest gains, though the chip industry generally adopted a wait-and-see approach before the earnings announcement.NVIDIA Corporation, NVDATechnology Software Sector Under PressureSoftware companies faced significant headwinds at Wednesday’s opening. Intuit tumbled nearly 12% despite surpassing quarterly profit expectations, with the decline stemming from revenue projections that significantly undershot analyst targets.The financial software provider forecast fiscal 2027 full-year revenue in the $23.28 billion to $23.51 billion range, missing the Street’s $23.7 billion expectation. Additionally, the company’s non-GAAP earnings per share guidance of $22.68 to $23.12 came in substantially below the $27.30 consensus.Chief Executive Sasan Goodarzi emphasized the company’s strategy to capture increased market share within the increasingly competitive artificial intelligence software landscape.ServiceNow, Adobe, and Atlassian each retreated more than 2%. Salesforce declined 1.6% in advance of its earnings disclosure scheduled for after the closing bell. Palantir shed 1.2%.SAP plunged nearly 5% after receiving a downgrade from UBS, which moved the stock from buy to neutral. The firm’s analysts pointed to sluggish advancement in delivering AI products to enterprise customers, raising concerns that clients might pursue in-house AI development instead.nCino declined 4% following revenue guidance that disappointed market expectations. Zoom dropped more than 5% even after exceeding analyst projections, partially due to the absence of updated information regarding the valuation of its Anthropic investment.Cryptocurrency Retreat Impacts Related EquitiesBitcoin experienced a pullback to the $78,500 level after reaching heights approaching $81,000 earlier in the trading week. This downturn created headwinds for cryptocurrency-associated stocks.Strategy decreased 1.7%, while Coinbase Global and Robinhood Markets each fell 1.4%.Positive Performers in Wednesday’s SessionSeveral companies bucked the broader weakness. Biohaven soared 13% following the announcement of a worldwide licensing partnership with SK Biopharmaceuticals. The deal structure includes upfront payments and milestone-based compensation totaling up to $795 million, alongside tiered royalty arrangements ranging from the mid-teens to low twenties percentage on domestic net sales.Semtech climbed 3.2% after delivering second-quarter revenue of $341.9 million, representing 32.7% year-over-year growth, with both results and forward guidance exceeding analyst expectations.HEICO advanced 2.5% following the disclosure of record quarterly revenue reaching $1.41 billion, up 23% compared to the year-ago period, surpassing the consensus projection of $1.35 billion.Summit Therapeutics rose 5.5% after collaboration partner Akeso shared favorable Phase III clinical trial outcomes for a cancer therapy combining ivonescimab with chemotherapy.Spyre Therapeutics dropped 12% following mixed Phase 2 data for its rheumatoid arthritis drug candidate, where the lower dose achieved the primary endpoint while the higher dose failed to meet targets.Market attention remains concentrated on Nvidia’s after-hours earnings release, alongside quarterly reports from Salesforce, Okta, CrowdStrike, and Nutanix.The post Market Update: Nvidia (NVDA) Earnings Anticipation, Software Sector Decline, and Crypto Retreat appeared first on Blockonomi.